Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics
- 19 October 2010
- journal article
- case report
- Published by Physicians Postgraduate Press, Inc in British Journal of Psychology
- Vol. 72 (08), 1063-1071
- https://doi.org/10.4088/jcp.09r05535gre
Abstract
From The Journal of Clinical Psychiatry:Keywords
This publication has 25 references indexed in Scilit:
- Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.2009
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive DisorderBritish Journal of Psychology, 2009
- Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D ReportAmerican Journal of Psychiatry, 2008
- Aripiprazole Monotherapy in Nonpsychotic Bipolar I DepressionJournal of Clinical Psychopharmacology, 2008
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive DisorderBritish Journal of Psychology, 2007
- A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive DisorderBritish Journal of Psychology, 2007
- Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.2006
- Typical and Atypical Antipsychotics in Bipolar DepressionPublished by Physicians Postgraduate Press, Inc ,2005
- Off-label indications for atypical antipsychotics: A systematic reviewAnnals of General Hospital Psychiatry, 2004
- Using Numerical Results from Systematic Reviews in Clinical PracticeAnnals of Internal Medicine, 1997